Expecting unexpected AEs can reduce IRB reporting burden; FDA not inclined to expand DMCs to help out.(Adverse events)(Institutional Review ... An article from: Bioresearch Monitoring Alert

This digital document is an article from Bioresearch Monitoring Alert, published by Washington Information Source on December 1, 2003. The length of the article is 1469 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Expecting unexpected AEs can reduce IRB reporting burden; FDA not inclined to expand DMCs to help out.(Adverse events)(Institutional Review Boards)(United States. Food and Drug Administration)(data monitoring committees)
Author: Tamra Sami
Publication:Bioresearch Monitoring Alert (Newsletter)
Date: December 1, 2003
Publisher: Washington Information Source
Volume: 3 Issue: 12 Page: 1

Distributed by Thomson Gale